The following discussion and analysis of the financial condition and results of
operations of Astra Space, Inc. should be read together with our audited
consolidated financial statements as of and for the years ended December 31,
2021 and 2020 and unaudited interim condensed consolidated financial statements
as of and for the three and nine months ended September 30, 2022 and 2021,
together with related notes thereto. This discussion may contain forward-looking
statements based upon current expectations that involve risks and uncertainties.
Our actual results may differ materially from those projected in these
forward-looking statements as a result of various factors, including those set
forth in the risk factors previously disclosed in our annual report on Form 10-K
for the year ended December 31, 2021, filed with the SEC on March 31, 2022, as
updated by factors disclosed in the section titled "Risk Factors" in this
Quarterly Report on Form 10-Q and our Quarterly Report on Form 10-Q for the
quarter ended June 30, 2022, filed with the SEC on August 4, 2022 and in this
Quarterly Report on Form 10-Q. Certain amounts may not foot due to rounding.
Unless the context otherwise requires, all references in this section to "the
Company" "Astra," "us," "our" or "we" refer to Astra Space, Inc. after the
closing of the Business Combination on June 30, 2021, and Astra Space
Operations, Inc., formerly known as Astra Space, Inc., prior to the Business
Combination.

Overview

Our mission is to launch a new generation of launch services and space products
to Improve Life on Earth from Space®. These services and products are enabled by
new constellations of small satellites in Low Earth Orbit ("LEO"), which have
rapidly become smaller, cheaper, and many times more numerous than legacy
satellites. Launch vehicles, however, have not evolved in the same way - most
rockets remain focused on serving legacy satellites and human spaceflight
missions and we aim to provide the world's first mass-produced orbital launch
system. We manage our business and report our financial results in two segments:
Launch Services and Space Products.

Launch Services



In July 2022, we decided to focus on the development and production of the next
version of our launch system, which we unveiled at our inaugural SpaceTech Day
on May 12, 2022. As a result, we have discontinued the production of launch
vehicles supported by our current launch system and do not plan to conduct any
further commercial launches in 2022. As part of the development cycle for our
new launch system, we expect to conduct test launches of our new launch system
in the later part of 2023, and at this time, do not expect that we will be able
to conduct paid commercial launches until 2024 using this new launch system.
Whether and when we will be able to conduct paid commercial launches in 2024
will depend in part upon the success of these test launches.

Our new launch system is intended to support launch vehicles that will serve a
market focused on populating mega constellations. We have designed this launch
system to support more payload capacity, greater reliability, and a more
frequent launch cadence, which we believe will allow us to offer our customers
more dependable services. We have begun discussions with customers for whom we
agreed to launch payloads on our Rocket 3 series launch vehicles (aka launch
system 1.0) and the shift of those flights to our Rocket 4 series (aka Launch
System 2).

Space Products

We have also been focusing on the growth of our space products business with
sales of our Astra Spacecraft EngineTM. The Astra Spacecraft Engine is a
propulsion engine that assists satellites in achieving and maintaining targeted
orbits. Including 14 units in Apollo Fusion's backlog on July 1, 2021, we have
received cumulative committed orders for 214 Astra Spacecraft EnginesTM as of
September 30, 2022, an increase of 107.8% compared to June 30, 2022, and 237
Astra Spacecraft Engines™ as of November 2, 2022, an increase of 130% compared
to June 30, 2022. We have also completed the delivery of two full programs of
our Astra Spacecraft Engines™.

Segments



As discussed in Note 16 - Segments Information to our consolidated financial
statements included in Part I, Item 1 of this form 10-Q, our reportable segments
changed during the three and nine months ended September 30, 2022. The segment
reporting for prior periods has been reclassified to conform to the current
period presentation; however, there were no revenues or cost of revenues
associated to these segments in the prior period.

We identify our reporting segments based on the organizational units used by
management to monitor performance and make operating decisions. The Company
previously had one operating and reportable segment. Following the realignment,
the Company now has the following two operating and reportable segments: (i)
Launch Services and (ii) Space Products. In conjunction with the realignment of
our management and internal reporting in the third quarter of 2022, the Company
reclassified assets and liabilities, as well as goodwill, to the reporting
units.


                                       35

--------------------------------------------------------------------------------


  Table of Contents


COVID-19 Impact

On March 11, 2020, the World Health Organization declared the novel strain of
coronavirus ("COVID-19") a global pandemic and recommended containment and
mitigation measures worldwide. The extent of the impact of the coronavirus
pandemic on Astra's operational and financial performance will depend on various
future developments, including variants of the disease, the duration and spread
of the outbreak and impact on its customers, suppliers, and employees, all of
which is uncertain at this time. Astra believes the COVID-19 pandemic may
adversely impact future revenue and results of operations, but Astra is unable
to predict at this time the size and duration of this adverse impact. Astra has
seen some signs of positive effects for its long-term business prospects and
partnerships as a result of the pandemic. The COVID-19 pandemic has created an
even greater need for broadband internet access, and businesses are thinking
differently about how their workforce can stay connected. There have also been
recent government and commercial announcements about continuous investments in
this area and we believe this will continue to support the growth of the small
satellite market for the foreseeable future.

Key Factors Affecting Our Results and Prospects



We believe that our performance and future success depend on a number of factors
that present significant opportunities for us but also pose risks and
challenges, including competition from better known and well-capitalized
companies, the risk of actual or perceived safety issues and their consequences
for our reputation, the potential delisting of our Class A common stock from the
NASDAQ Global Select Market, our ability to operate as a going concern and the
other factors discussed under "Risk Factors" in our Annual Report on Form 10-K
for the period ended December 31, 2021, filed with the SEC on March 31, 2022, as
updated by factors disclosed in the section titled "Risk Factors" in this
Quarterly Report on Form 10-Q and in our Quarterly Report for the quarter ended
June 30, 2022, filed with the SEC on August 4, 2022. We believe the factors
discussed below are key to our success.

Commencing and Expanding Commercial Operations



We commenced paid commercial launch services in 2022, with our launch on
February 10, 2022, of launch vehicle LV0008. We have made substantial progress
towards demonstrating a monthly launch production capability during the first
three quarters of 2022, with a goal of reaching an even more frequent launch
production capability in the future with our new Launch System 2. As a result,
we have decided to focus on the development of our new launch system and thus,
have discontinued the production of launch vehicles supported by our current
launch system. When we refer to a "commercial launch," we mean a launch
conducted under an FAA commercial launch license.

We also commenced delivery of space products during the second quarter of 2022.
We expect the volume of delivery of our space products would increase in the
future as we continue to fulfill our obligations under existing space products
contracts and enter into contracts with potential new customers. In late July
2022, the Company entered into a lease agreement for approximately 60,000 square
feet of manufacturing facility in Sunnyvale, California having a lease term of
36 months. This new lease facility will enable expansion of our space products
production and development capacity, thermal testing capacity.

Lowering Manufacturing Costs and Increasing Payloads



We aim to be a cost-efficient dedicated orbital launch system provider. We plan
to increase the maximum payload capacity of our launch vehicle to meet customer
needs and demands through a process of iterative development and improvement. We
have made significant investment in our manufacturing facility located in
Alameda, California. Please see risk factors previously disclosed in our Annual
Report on Form 10-K for the period ended December 31, 2021, filed with the SEC
on March 31, 2022, as updated by factors disclosed in the section titled "Risk
Factors" in this Quarterly Report on Form 10-Q and our Quarterly Report on Form
10-Q for the quarter ended June 30, 2022, filed with the SEC on August 4, 2022,
for factors that could affect our ability to realize benefits from the
investment in our manufacturing facility.

Leveraging Core Technologies



We plan to develop, license or acquire core space technologies that we expect to
commercialize and incorporate into our launch vehicles, spacecrafts and other
infrastructure that we will use to deliver our product and space service
offerings. These core technologies including, among other things, electric
propulsion and solar power. For example, we acquired propulsion technology
through our merger with Apollo Fusion, which we announced on June 2, 2021, and
closed on July 1, 2021.

Expand Our Space Services Offerings



As of September 30, 2022, we were in the preliminary stages of developing our
space services offering, but have since decided to put these development efforts
on hold as we focus on our primary objectives of developing our new Launch
System 2 and the production and delivery of our Astra Spacecraft Engines™. As a
result, we do not expect to generate any revenue and are planning to reduce our
investments in our space services offerings for the remainder of 2022 and in
2023. We continue to explore opportunities to develop or

                                       36

--------------------------------------------------------------------------------

Table of Contents




partner in the development of our space services offering as it remains a
significant part of our long-term business strategy. Once developed, we would
expect our space services offering to include providing modular configurable
satellite buses for customers, leveraging both in-house and partner-provided
subsystem components and in-house design and integration services, as well as
operational support of satellites on orbit, to turn-key provision of entire
constellations, offering "concept to constellation" in months instead of years.
Specifically, we would expect our space services to encompass all aspects of
hosted satellite and constellation services, including hosting customer payloads
onto our satellites, and delivering services, such as communication services.
These services are expected to allow customers to focus on developing innovative
payloads rather than having to design or develop complete satellite buses or
satellites or constellations, which we will provide, along with ancillary
services that are likely to include telemetry, tracking and control ("TT&C"),
communications, processing, as well as software development and maintenance.

Impairment of long-lived assets, indefinite-lived intangible assets and goodwill



As of the third quarter of fiscal year 2022, the Company determined that
impairment indicators were present based on the existence of substantial doubt
about the Company's ability to continue as a going concern, a sustained decrease
in the Company's share price and macroeconomic factors. As a result, we
performed quantitative impairment testing and recorded a total impairment charge
of $133.4 million for the three and nine months ended September 30, 2022. The
total impairment charge reflects a $58.3 million charge in goodwill, $2.1
million charge in indefinite-lived intangible assets and $73 million in
long-lived assets of Launch Services related to property, plant and equipment.
For further information, refer to Note 1 - Description of Business, Basis of
Presentation and Significant Accounting Policies, Note 4 - Supplemental
Financial Information, and Note 5 - Goodwill and Intangible Assets to our
condensed consolidated financial statements included in Part I, Item 1 of this
form 10-Q.

Key Components of Results of Operations



We are an early-stage company and our historical results may not be indicative
of our future results for reasons that may be difficult to anticipate.
Accordingly, the drivers of our future financial results, as well as the
components of such results, may not be comparable to our historical or future
results of operations.

Revenues

We commenced our first paid commercial launch, which occurred in February 2022,
followed by subsequent paid commercial launches which occurred in March 2022 and
June 2022. These launches represent the start of our paid commercial launch
operations. As discussed earlier, we have discontinued the production of launch
vehicles supported by our current launch system and do not plan to conduct any
further commercial launches in 2022. See "Overview" for more information about
our decision to stop producing launch vehicles supported by our current launch
system.

We also commenced delivery of space products to our customers during the three
and nine months ended September 30, 2022. As we are in the very early stages of
developing our space services offering and have decided to put these development
activities on hold for the near future, we do not expect to generate revenues by
delivering space services to our customers at this time.

Cost of Revenues



Cost of revenues consist primarily of direct material, direct labor,
manufacturing overhead, other personnel-related expenses, which include
salaries, bonuses, benefits and stock-based compensation expense and
depreciation expense. Cost of revenues also includes inventory write-downs to
reduce the carrying value of inventory related to launch services when the
carrying value exceeds its estimated net realizable value. We anticipate
recording write-downs to our inventory over the foreseeable future as we
continue to ramp production of launch vehicles supported by our new launch
system. We expect our cost of revenues to increase in future periods as we sell
more launch services and space products. As we grow into our current capacity
and execute on cost-reduction initiatives, we expect our gross margins to
improve over time.

Operating Expenses

Research and Development Expense



Our research and development expenses consist primarily of internal and external
expenses incurred in connection with our research activities and development
programs. These expenses include, but are not limited to, development supplies,
testing materials, personnel and personnel-related costs (including salaries,
bonuses, benefits, and stock-based compensation expense), depreciation expense,
amortization of intangible assets, overhead allocation (consisting of various
support and facility costs) and consulting fees. Research and development costs
are expensed as incurred.

                                       37

--------------------------------------------------------------------------------

Table of Contents




We allocate research and development costs by function rather than by project,
as a significant majority of our historical research and development spending
was related to the initial development and testing of our underlying technology,
including preparation for multiple test launches.

Our current primary research and development objectives focus on the development
and finalization of our offerings. The successful development of these offerings
involves many uncertainties, including:

timing in finalizing launch and space systems design and specifications;

successful completion of analyses and ground test programs to validate that new or changed designs perform as expected;

successful completion of flight test programs, including flight safety tests;

our ability to obtain additional applicable approvals, licenses or certifications from regulatory agencies, if required, and maintaining current approvals, licenses or certifications;

performance of our manufacturing facilities despite risks that disrupt productions, such as natural disasters and hazardous materials;

performance of a limited number of suppliers for certain raw materials and components;

performance of our third-party contractors that support our research and development activities;

our ability to maintain rights from third parties for intellectual properties critical to research and development activities; and

our ability to continue funding and maintaining our current research and development activities.



A change in the outcome of any of these variables could delay the development of
our launch systems and space products, which in turn could impact the timing of
commercialization of our offerings.

As we are developing and building our launch services, we have expensed all
research and development costs associated with developing and building our
launch services offering. We expect that our research and development expenses
will increase in the short-term as we invest in improving and further reducing
the costs of our launch system.

Sales and Marketing Expense



Sales and marketing expenses consist of personnel and personnel-related expenses
(including stock-based compensation expense) for our business development team
as well as advertising and marketing expenses. We expect to increase our sales
and marketing activities in order to grow our customer base and increase market
share in the future.

General and Administrative Expense



General and administrative expenses consist primarily of personnel and
personnel-related costs (including salaries, bonuses, benefits, and stock-based
compensation expense) for personnel in executive, finance, accounting, corporate
development and other administrative functions. General and administrative
expenses also include legal fees, professional fees paid for accounting,
auditing, consulting, tax, and investor relations services, insurance costs, and
facility costs not otherwise included in research and development expenses and
costs associated with compliance with the rules and regulations of the SEC and
the stock exchange.

Income Tax (Benefit) Expense

Our income tax provision consists of an estimate for U.S. federal and state income taxes based on enacted rates, as adjusted for allowable credits, deductions, uncertain tax positions, changes in deferred tax assets and liabilities, and changes in the tax law. We maintain a valuation allowance against the full value of our U.S. and state net deferred tax assets because we believe the recoverability of the tax assets is not more likely than not.

Other Income (Expense), Net

Other income (expense), net primarily consists of income from government research and development contracts.

Critical Accounting Estimates



Our financial statements have been prepared in accordance with U.S. generally
accepted accounting principles, or U.S. GAAP. Preparation of the financial
statements requires our management to make a number of judgments, estimates and
assumptions relating to the reported amount of assets and liabilities and
disclosure of contingent assets and liabilities at the date of the financial
statements

                                       38

--------------------------------------------------------------------------------

Table of Contents




and the reported amounts of revenue and expenses during the reporting period. We
consider an accounting judgment, estimate or assumption to be critical when (1)
the estimate or assumption is complex in nature or requires a high degree of
judgment and (2) the use of different judgments, estimates and assumptions could
have a material impact on our consolidated financial statements. Our significant
accounting policies are described in Note 2 in our Annual Report on Form 10-K
for the year ended December 31, 2021, as updated as applicable in Note 1 to the
condensed consolidated financial statements herein.

Except as outlined below, there were no significant changes in our critical
accounting estimates during the three and nine months ended September 30, 2022
compared to those previously disclosed in "Critical Accounting Estimates" in
"Management's Discussion and Analysis of Financial Condition and Results of
Operations" included in the 2021 Annual Report on Form 10-K.

Goodwill and indefinite-lived intangible assets

Goodwill and indefinite-lived intangible assets are not subject to amortization.
We perform an annual impairment review of goodwill and indefinite-lived
intangible assets during the fourth fiscal quarter of each year, and more
frequently if we believe that indicators of impairment exist. We compare the
fair value of our reporting unit to the respective carrying amount and recognize
an impairment charge for the amount by which the carrying amount exceeds the
reporting unit's fair value.

We believe that estimating for goodwill and indefinite-lived intangible assets
requires significant judgments that are based on several factors including
operating results and market conditions. We estimate fair value through various
valuation methods, including the use of discounted expected future cash flows of
each reporting unit, as well as the use of the relief-from-royalty method to
estimate the fair value of our indefinite-lived intangible asset. During the
third quarter of fiscal year 2022, we reorganized our reporting structure and
determined to perform an interim quantitative impairment test. As a result, for
the nine months ended September 30, 2022, we recognized impairment losses
related to goodwill and indefinite-lived intangible assets of $58.3 million and
$2.1 million, respectively.

Long-lived assets

Long-lived assets are primarily comprised of property, plant, and equipment and
definite-lived intangible assets. We evaluate long-lived assets for impairment
when events or changes in circumstances indicate, in management's judgement,
that the carrying amount of such assets may not be recoverable. Long-lived asset
recoverability is measured by comparing the carrying amount of the asset group
with its estimated future undiscounted pre-tax cash flows over the remaining
life of the primary long-lived asset of the asset group. If the carrying amount
exceeds the estimated future undiscounted cash flows as part of the
recoverability assessment, an impairment charge is recognized equal to the
difference between the carrying amount and fair value of the asset group. The
impairment charge is allocated to the underlying long-lived assets in the asset
group on a relative carrying amount basis; however, carrying amount after
allocated impairment is subject to a floor of fair value on an individual asset
basis.

We believe the accounting estimates used in the long-lived asset impairment
assessment are critical accounting estimates because of the judgment required in
identifying indicators of impairment, determining asset groups, assessing future
undiscounted cash flows of the asset groups, and as applicable, evaluating the
fair value of the determined asset groups as well as the underlying long-lived
assets, once indicators of impairment have been identified. As a result of the
reorganization, together with a sustained decrease in the Company's share price,
existence of substantial doubt about the Company's ability to continue as a
going concern, and macroeconomic factors we determined that triggers were
present indicating long lived assets may not be recoverable. For the nine months
ended September 30, 2022, we concluded that indicators of impairment were
present and recorded a non-cash impairment charge on long-lived assets of $70.3
million related to property, plant, and equipment and $2.7 million related to
definite-lived intangible assets.

                                       39

--------------------------------------------------------------------------------


  Table of Contents


Results of Operations

Comparison of the Three and Nine months ended September 30, 2022 and 2021



                          For The Three Months               Period over                 For The Nine Months                Period over
                          Ended September 30,               period change                Ended September 30,               period change
(in thousands,
except percentages)       2022              2021          ($)            (%)             2022              2021          ($)            (%)
Revenues:
Launch services       $           -       $      -              -          n.m.     $         5,899      $      -     $    5,899          n.m.
Space products                2,777              -          2,777          n.m.               3,471             -          3,471          n.m.
Total revenues                2,777              -          2,777             -               9,370             -          9,370             -

Cost of revenues:
Launch services                   -              -              -          n.m.              28,193             -         28,193          n.m.
Space products                1,071              -          1,071          n.m.               1,337             -          1,337          n.m.
Total cost of
revenues                      1,071              -          1,071             -              29,530             -         29,530             -

Gross profit
(loss):
Launch services                   -              -              -          n.m.             (22,294 )           -        (22,294 )        n.m.
Space products                1,706              -          1,706          n.m.               2,134             -          2,134          n.m.
Total gross profit
(loss)                        1,706              -          1,706             -             (20,160 )           -        (20,160 )           -


____________

n.m. = not meaningful.

Revenues

Revenues were $2.7 million for the three months ended September 30, 2022. All of
which was related to space products. We commenced delivery of space products to
our customers during the three months ended September 30, 2022. No revenues were
recognized during the three months ended September 30, 2021.

Revenues were $9.4 million for the nine months ended September 30, 2022 of which
$5.9 million related to launch services and $3.4 million related to space
products. We commenced paid commercial launch services and delivery of space
products during the nine months ended September 30, 2022. We launched launch
vehicles LV0008, LV0009 and LV0010 on February 10, 2022, March 15, 2022 and June
12, 2022, respectively, all of which were paid launches. The orbital launch of
LV0009 conducted on March 15, 2022, represents our first paid delivery of
customer payloads into Earth orbit. No revenues were recognized for the nine
months ended September 30, 2021. We do not anticipate any revenues related to
our launch services business in 2023 as we work to develop and test the next
version of our launch system: Launch System 2.

Cost of Revenues



Cost of revenues were $1.1 million for the three months ended September 30, 2022
which was driven by the cost of space products. The cost of space products does
not reflect the actual gross margins as certain inventory values were recorded
at net realizable value. No cost of revenues were recognized for the three
months ended September 30, 2021.

                                       40

--------------------------------------------------------------------------------

Table of Contents




Cost of revenues were $29.5 million for the nine months ended September 30, 2022
which was primarily driven by recording of $18.8 million of inventory
write-downs and $6.9 million of cost of launch services and space products. The
$18.8 million of inventory write-downs was driven by $10.2 million related to
the discontinuance of launch vehicles supported by our current launch system,
$5.5 million related to the net realizable value write-downs and $3.1 million of
other write-downs. The cost of launch services does not reflect the actual gross
margins as certain inventory values were recorded at net realizable value. In
the first nine months of 2022, we conducted our first paid commercial launch and
have not yet achieved economies of scale in our manufacturing processes. We also
decided to stop paid commercial launches for the remainder of 2022 so that we
can focus on developing our new launch system. As a result, we will continue to
incur negative gross margins for the remainder of 2022. No cost of revenues were
recognized for the nine months ended September 30, 2021.

                            For The Three Months              Period over                For The Nine Months               Period over
                             Ended September 30,             period change               Ended September 30,              period change
(in thousands, except
percentages)                 2022           2021           ($)            (%)           2022            2021             ($)           (%)
Operating expenses:
Research and
development                    32,821        21,724         11,097             1        111,546           44,159          67,387           2
Sales and marketing             4,052         1,090          2,962           272         13,452            2,229          11,223         503
General and
administrative                 19,222        19,730           (508 )          (3 )       60,816           50,712          10,104          20
Impairment expense             75,116             -         75,116          n.m.         75,116                -          75,116        n.m.
Goodwill impairment            58,251             -         58,251          n.m.         58,251                -          58,251        n.m.
Loss on change in fair
value
  of contingent
consideration                  11,949             -         11,949          n.m.         29,249                -          29,249        n.m.
Total operating
expenses                      201,411        42,544        158,867           373        348,430           97,100         251,330         259
Operating loss               (199,705 )     (42,544 )     (157,161 )        

(373 ) (368,590 ) (97,100 ) (271,490 ) 280 Interest (expense) income,


  net                             616            18            598         3,322          1,146           (1,194 )         2,340        (196 )
Other income (expense),
net                               (25 )      25,895        (25,920 )        (100 )          314           25,177         (24,863 )       (99 )
Loss on extinguishment
of
  convertible notes                 -             -              -          n.m.              -         (131,908 )       131,908        n.m.
Loss on extinguishment
of
  convertible notes
attributable
  to related parties                -             -              -          n.m.              -           (1,875 )         1,875        n.m.
Loss before taxes            (199,114 )     (16,631 )     (182,483 )       

1,097 (367,130 ) (206,900 ) (160,230 ) 77 Income tax (benefit) expense

                             -          (383 )          383          n.m.              -             (383 )           383        n.m.
Net loss                  $  (199,114 )   $ (16,248 )   $ (182,866 )

1,125 $ (367,130 ) $ (206,517 ) (160,613 ) 78 Adjustment to redemption

value on Convertible


  Preferred Stock                   -             -              -          n.m.              -       (1,011,726 )     1,011,726        n.m.
Net loss attributable
to

common stockholders $ (199,114 ) $ (16,248 ) $ (182,866 ) 1125 % $ (367,130 ) $ (1,218,243 ) $ 851,113 (70 )




____________

n.m. = not meaningful.

Research and Development

Research and development costs were $32.8 million for the three months ended
September 30, 2022, compared to $21.7 million for the three months ended
September 30, 2021. The $11.1 million increase mainly reflected a $4.3 million
increase in stock-based compensation expense, a $2.3 million increase in
depreciation and amortization expense, a $2.3 million increase in third party
consulting and recruitment costs offset by a $1.2 million decrease in technology
licensed and software subscription licenses related expenses with the remainder
due to changes in other research and development expenses. These increases were
to support our product roadmap and launch services.

Research and development costs were $111.5 million for the nine months ended
September 30, 2022, compared to $44.2 million for the nine months ended
September 30, 2021. The $67.4 million increase mainly reflected a $24.5 million
increase in personnel-related costs due to headcount increases in research and
development departments, a $9.7 million increase in research and development
materials expense, a $13.3 million increase in stock-based compensation expense,
a $7.8 million increase in third party consulting and recruitment costs, a $6.7
million increase in depreciation and amortization expense and a $0.7 million
increase in technology licensed and software subscription licenses related
expenses with the remainder due to changes in other research and development
expenses. These increases were to support our product roadmap and launch
services.

                                       41

--------------------------------------------------------------------------------


  Table of Contents


Sales and Marketing

Sales and marketing expenses were $4.1 million for the three months ended
September 30, 2022, compared to $1.1 million for the three months ended
September 30, 2021. The $3.0 million increase mainly reflected a $1.5 million in
stock-based compensation expense, $1.3 million increase in personnel-related
costs, with the remainder due to changes in other sales and marketing expenses.
These increases were to support business development and marketing activities.

Sales and marketing expenses were $13.5 million for the nine months ended
September 30, 2022, compared to $2.2 million for the nine months ended September
30, 2021. The $11.2 million increase mainly reflected a $4.7 million increase in
personnel-related costs, a $4.5 million in stock-based compensation expense and
a $0.8 million increase in depreciation expense with the remainder due to
changes in other sales and marketing expenses. These increases were to support
business development and marketing activities.

General and Administrative



General and administrative expenses were $19.2 million for the three months
ended September 30, 2022, compared to $19.7 million for the three months ended
September 30, 2021. The $0.5 million decrease was primarily due to a $5.7
million decrease in insurance related expenses, $4.3 million decrease from
transaction costs incurred and expensed by the Company in relation to the
Business Combination, offset by a $5.1 million decrease in stock-based
compensation expense, a $1.6 million increase in third party consulting and
recruitment costs, $0.7 million increase in employee costs due to increased
headcount, $0.3 million increase in accounting, audit and legal related fees
which is partially with the remainder due to changes in facilities costs, IT
equipment fees, and other services.

General and administrative expenses were $60.8 million for the nine months ended
September 30, 2022, compared to $50.7 million for the nine months ended
September 30, 2021. The $10.1 million increase was primarily due to a $11.1
million increase in employee costs due to increased headcount, a $5.3 million
increase in stock-based compensation expense, a $4.0 million increase in
accounting, audit and legal related fees, a $1.6 million increase in third party
consulting and recruitment costs offset by $8.0 million decrease from
transaction costs incurred and expensed by the Company in relation to the
Business Combination, $2.0 million decrease in insurance related expenses with
the remainder due to changes in facilities costs, IT equipment fees, and other
services.

Impairment Expense

Impairment expense was $75.1 million for the three and nine months ended
September 30, 2022 and was triggered by the existence of substantial doubt about
the Company's ability to continue as a going concern, a sustained decrease in
the Company's share price and macroeconomic factors. The impairment expense
reflects charges of $70.3 million in property, plant and equipment, $2.7 million
in definite-lived intangible assets, and $2.1 million in indefinite-lived
intangible assets. No impairment charges were recorded for the three and nine
months ended September 30, 2021.

Goodwill Impairment

Goodwill impairment was $58.3 million for the three and nine months ended
September 30, 2022 and was triggered by the existence of substantial doubt about
the Company's ability to continue as a going concern, a sustained decrease in
the Company's share price and other macroeconomic factors. The expense reflects
the full impairment of the Company's goodwill balance. No goodwill impairment
was recorded for the three and nine months ended September 30, 2021.

Loss on Change in Fair Value of Contingent Consideration



Loss on change in fair value of contingent consideration of $11.9 million and
$29.2 million for the three and nine months ended September 30, 2022,
respectively, was due to higher revenues forecasted in estimating the fair value
of contingent consideration. No loss on change in fair value of contingent
consideration was recorded for the three and nine months ended September 30,
2021.

Interest (Expense) Income, Net



Interest income was $0.6 million for the three months ended September 30, 2022,
compared to interest expense of less than $0.1 million for the three months
ended September 30, 2021. The $0.6 million increase in interest (expense)
income, net was primarily due to the settlement of outstanding debt during the
year ended December 31, 2021. Therefore, we did not incur any interest expense
during the period and an increase of $0.4 million in interest income related
during the three months ended September 30, 2022.

Interest income was $1.1 million for the nine months ended September 30, 2022,
compared to interest expense of $1.2 million for the nine months ended September
30, 2021. The $1.7 million increase in interest (expense) income, net was
primarily due to the settlement of outstanding debt during the year ended
December 31, 2021. Therefore, we did not incur any interest expense during the
period and an increase of $0.8 million in interest income related to investment
in marketable securities during the nine months ended September 30, 2022.

                                       42

--------------------------------------------------------------------------------


  Table of Contents


Other Income (Expense), Net

Other expense, net was less than $0.1 million for the three months ended
September 30, 2022, compared to other income, net of $25.9 million for the three
months ended September 30, 2021. The $26.0 million decrease in other income was
primarily due to $20.4 million in income from change in fair value of warrant
liability, $4.9 million in income from a gain on forgiveness of PPP Note and
$0.6 million in income from government research and development contracts for
the three months ended September 30, 2021.

Other income, net was $0.3 million for the nine months ended September 30, 2022,
compared to other income, net of $25.2 million for the three months ended
September 30, 2021. The $24.9 million decrease in other income was primarily due
to $20.4 million in income from change in fair value of warrant liability, $4.9
million in income from a gain on forgiveness of PPP Note and $0.6 million in
income from government research and development contracts for the nine months
ended September 30, 2021 offset by $0.8 million due to a nonrecurring payment to
one of our investors for the nine months ended September 30, 2021.

Loss on Extinguishment of Convertible Notes

No loss on extinguishment of convertible notes was recorded for the three months ended September 30, 2022 and 2021.



No loss on extinguishment of convertible notes was recorded for the nine months
ended September 30, 2022. Loss on extinguishment of convertible notes of $131.9
million was recorded for the nine months ended September 30, 2021 due to the
settlement of convertible notes on January 28, 2021.

Loss on Extinguishment of Convertible Notes Attributable to Related Parties

No loss on extinguishment of convertible notes attributable to related parties was recorded for the three months ended September 30, 2022 and 2021.



No loss on extinguishment of convertible notes attributable to related parties
was recorded for the nine months ended September 30, 2022. Loss on
extinguishment of convertible notes attributable to related parties of $1.9
million was recorded for the nine months ended September 30, 2021 due to the
settlement of convertible notes attributable to related parties on January 28,
2021.

Income Tax (Benefit) Expense

We did not incur income tax expense for the three and nine months ended September 30, 2022.

We recorded an income tax benefit of $0.4 million as the result of Apollo acquisition for the three months and nine months ended September 30, 2021.

Adjustment to redemption value on Convertible Preferred Stock

No adjustment to redemption value on convertible preferred stock was recorded for the three months ended September 30, 2022.



No adjustment to redemption value on convertible preferred stock was recorded
for the nine months ended September 30, 2022. Adjustment to redemption value on
Convertible Preferred Stock of $1,011.7 million for the nine months ended
September 30, 2021 was recorded due to the re-measurement of Convertible
Preferred Stock to its redemption value due to the likelihood of a redemption
event becoming probable.

Liquidity and Capital Resources



The following section discusses our principal liquidity and capital resources as
well as our primary liquidity requirements and uses of cash. Our cash and cash
equivalents are maintained in highly liquid investments with remaining
maturities of 90 days or less at the time of purchase. We believe our cash
equivalents are liquid and accessible.

We measure liquidity in terms of our ability to fund the cash requirements of
our research and development activities and our current business operations,
including our capital expenditure needs, contractual obligations and other
commitments. Our current liquidity needs relate to business operations, research
and development activities, mainly in connection with the ongoing development of
our technology, lease obligations and capital expenditures, which primarily
relate to the development of our manufacturing facility.

Given our current liquidity position and historical operating losses, we believe
there is substantial doubt that we can continue as a going concern. Substantial
doubt about an entity's ability to continue as a going concern exists when
conditions and events, considered in the aggregate, indicate that it is probable
that the entity will be unable to meet its obligations as they become due within
one year after the date that the financial statements are issued. See Part II,
Item 1A "Risk Factors" for information about the risks related to our ability to
continue operating as a going concern.

                                       43

--------------------------------------------------------------------------------

Table of Contents




We have, however, prepared the condensed consolidated financial statements
included elsewhere in this Quarterly Report on Form 10-Q on a going concern
basis, assuming that our financial resources will be sufficient to meet our
capital needs over the next twelve months. Accordingly, our financial statements
do not include adjustments relating to the recoverability and realization of
assets and classification of liabilities that might be necessary should we be
unable to continue in operation.

As of September 30, 2022, our existing sources of liquidity included cash and
cash equivalents of $67.6 million and marketable securities of $82.9 million. We
have a limited history of operations and have incurred negative cash flows from
operating activities and loss from operations in the past as reflected in the
accumulated deficit of $1,775.5 million as of September 30, 2022. We expect to
continue to incur operating losses due to the investments we intend to make in
its business, including the development of our products and services, although
we expect those losses to be offset by revenues recognized through the delivery
of our space products in 2023. Management remains focused on managing its cash
expenditures, including but not limited to, reducing its capital expenditures,
consulting services and re-focusing its hiring efforts. In addition, Management
continues to evaluate opportunities to strengthen our financial position,
including through the issuance of additional equity securities or by entering
into new financing arrangements, as appropriate. The Company believes that it
has limited cash resources at the current level to fund commercial scale
production and sale of its services and products. However, if we are able to
obtain additional financing and assuming our plans to manage capital
expenditures are effective, including savings expected to be realized from our
approximately 16% reduction in existing headcount implemented on November 8,
2022 (of which there can be no assurance), we would expect that our existing
sources of liquidity will be sufficient to fund operating and capital
expenditure requirements through at least 12 months from the date of filing this
Quarterly Report on Form 10-Q. The Company's current liquidity may not be
sufficient to meet the required long-term liquidity needs associated with
continued use of cash from operating activities at historical levels, in
addition to its other liquidity needs associated with its capital expenditures,
and other investing requirements and the Company is actively evaluating other
sources of liquidity to further support its long-term business operations. For
additional information regarding our cash requirements from contractual
obligations and lease obligations, see Note 11 - Commitments and Contingencies
and Note 9 - Leases in Part I, Item 1 of this Quarterly Report on Form 10-Q.

Committed Equity Purchases



On August 2, 2022, we entered into an $100 million Class A common stock purchase
agreement with B. Riley to support working capital and other general corporate
needs. Under the terms of this agreement, we have the right, without obligation,
to sell and issue up to $100 million of our Class A common stock over a period
of 24 months to B. Riley at the Company's sole discretion, subject to certain
limitations and conditions. See Note 13 - Stockholders' Equity in Part I, Item 1
of this Quarterly Report on Form 10-Q for more details.

Summary Statement of Cash Flows for the Nine Months Ended September 30, 2022 and 2021

The following table sets forth the primary sources and uses of cash and cash equivalents for the periods presented below:



                                        For The Nine Months                Period over
                                        Ended September 30,               period change
(in thousands)                          2022           2021             $              %
Net cash used in operating
activities                           $ (134,615 )   $   (79,576 )   $  (55,039 )           69 %
Net cash used in investing
activities                             (124,088 )       (41,280 )      (82,808 )          201
Net cash provided by financing
activities                                1,304         488,897       (487,593 )         (100 )
Net increase (decrease) in cash
and cash equivalents                 $ (257,399 )   $   368,041     $ (625,440 )         (170 )%


Cash Flows used in Operating Activities



Our cash flows from operating activities are significantly affected by our cash
expenditures to support the growth of our business in areas such as research and
development and general and administrative and working capital. Our operating
cash inflows include cash from milestone billing under certain space products
and launch services contracts. These cash inflows are offset by our payments to
suppliers for production materials and parts used in our manufacturing process
as we ramp up our production for space products, payments to our employees and
other operating expenses.

For the nine months ended September 30, 2022, net cash used in operating
activities was $134.6 million. The primary factors affecting the Company's
operating cash flows during the period were a net loss of $367.1 million. This
is offset by non-cash charges including stock-based compensation expense of
$43.6 million, inventory reserves including write-offs and net realizable value
write-downs of $18.8 million, loss on change in fair value of contingent
consideration of $29.2 million, depreciation and amortization expense of $12.1
million and non-cash lease expense of $1.4 million. Changes in operating working
capital items is mainly due to decrease in inventories of $15.5 million, trade
accounts receivable of $3.1 million, accrued expense and other current
liabilities of $2.1 million, other non-current assets of $1.3 million, and lease
liabilities of $1.2 million. Changes in operating working capital items was
partially

                                       44

--------------------------------------------------------------------------------

Table of Contents

offset by an increase in other non-current liabilities of $10.4 million, prepaid and other current assets of $3.8 million and accounts payable of $3.0 million.



For the nine months ended September 30, 2021, net cash used in operating
activities was $79.6 million. The primary factors affecting the Company's
operating cash flows during this period were net loss of $206.5 million and a
non-cash gain of $20.4 million due to change in fair value of warrant liability
and $4.9 million due to a gain on forgiveness of PPP Note, offset by non-cash
charges including a non-cash loss on extinguishment of convertible notes of
$133.8 million, stock-based compensation expense of $20.5 million, depreciation
and amortization expense of $3.9 million, and amortization of convertible note
debt discounts of $0.4 million. Changes in operating working capital items
primarily reflect the increase in inventories of $4.2 million, prepaid and other
current assets of $13.9 million, accounts payable of $1.3 million, accrued
expenses and other current liabilities of $11.3 million and decrease in other
non-current liabilities of $0.2 million.

Cash Flows used in Investing Activities



For the nine months ended September 30, 2022, net cash used in investing
activities was $124.1 million, which was comprised mainly of purchases of
marketable securities of $136.4 million, purchases of property, plant and
equipment of $40.0 million mainly related to the construction of our
manufacturing facility at our corporate headquarters in Alameda, California, and
acquisition of an indefinite-lived intangible trademark asset of $0.9 million.
This was partially offset by maturities of marketable securities of $47.3
million and proceeds from sales of marketable securities of $6.0 million.

For the nine months ended September 30, 2021, net cash used in investing
activities was $41.3 million, which was comprised mainly of cash paid as
purchase price consideration in the acquisition of Apollo Fusion, Inc., net of
cash acquired of $19.4 million, acquisition of an indefinite-lived intangible
trademark asset of $3.2 million and purchases of property, plant and equipment
of $18.7 million.

Cash Flows from Financing Activities



For the nine months ended September 30, 2022, net cash provided by financing
activities amounted to $1.3 million and consisted primarily of $1.3 million of
proceeds from the sale of shares of the Company's Class A common stock and
issuance of shares of Class A common stock under equity plans.

For the nine months ended September 30, 2021, net cash provided by financing
activities amounted to $488.9 million and consisted primarily of proceeds from
the Business Combination and private offering, net of transaction costs, of
$463.6 million, proceeds from the issuance of Series C of $30.0 million and
borrowings of $10.0 million, proceeds from the issuance of stock under equity
plans of $1.8 million, offset by repayments on borrowings of $16.4 million.

Commitments and Contractual Obligations

We are a party to operating leases primarily for land and buildings (e.g., office buildings, manufacturing and testing facilities and spaceport) and certain equipment (e.g., copiers) under non-cancellable operating leases. The following table summarizes our lease commitments as of September 30, 2022:



                                                    Minimum Lease
                                                     Commitment
                                                   (in thousands)
2022 (remainder)                                   $         1,010
2023                                                         4,069
2024                                                         3,941
2025                                                         3,233
2026                                                         2,075
Thereafter                                                   3,705

Total future undiscounted minimum lease payments $ 18,033 Less: Imputed Interest

                                       3,156
Total reported lease liability                     $        14,877



On July 28, 2022, the Company entered into a lease agreement for approximately
60,000 square feet of manufacturing facility in Sunnyvale, California having a
lease term of 36 months with an option to extend for a period of an additional
36 months. The undiscounted base rent payments for the first year of this lease
is approximately $1.8 million with a 4% increase in base rent for each
subsequent year. In addition to base rent, the Company will be responsible for
the management fee of 5% of the base rent. In lieu of a cash security deposit,
the Company is required to provide the landlord an irrevocable letter of credit
in the amount of $0.3 million. This

                                       45

--------------------------------------------------------------------------------

Table of Contents



new lease facility is expected to enable expansion of space product production
and development capacity, thermal testing capacity. The Company is finalizing
the build-out of this facility and is targeting the completion of that building
during the first quarter of 2023.

In order to reduce manufacturing lead times and to have access to an adequate
supply of components, we enter into agreements with certain suppliers to procure
component inventory based on our production needs. A significant portion of our
purchase commitments arising from these agreements consist of firm and
non-cancelable commitments. As of September 30, 2022, we had purchase
commitments aggregating $39.0 million for which we were or will become obligated
to make payments within 12 months to 60 months from the execution date of the
agreements. Of these, there are agreements containing an aggregate of $32.1
million in early termination penalties. For example, one of the supply agreement
penalties includes payment of 50% of the remaining purchase commitment at any
point during the contract term. In another agreement, we may terminate the
supply agreement by paying the balance on the remaining purchase commitment only
after the first anniversary of the commencement date. If this agreement is
terminated before the first anniversary of the commencement date, we have to pay
the entire contract amount of $9.6 million.

Apart from the aforementioned leases and purchase commitments, we do not have any other material contractual obligations, commitments or contingent obligations.

Compliance with the Continued Listing Standards of the NASDAQ Global Select Market ("NASDAQ")



On October 6, 2022, the Company received a deficiency notice from NASDAQ that it
was not in compliance with Rule 5450(a)(1) of the listing requirements because
its per share closing bid price has been below $1.00 for the last thirty
consecutive business days. This notice has no immediate effect on the listing of
the Company's Class A common stock. Pursuant to Rule 5810(c)(3)(A), the Company
has 180 calendar days, or until April 4, 2023, to regain compliance with the
minimum bid price requirement set forth in Rule 5450(a)(1) (the "Minimum Bid
Price Requirement").

Nasdaq's notice stated that if, at any time before April 4, 2023, the per share closing bid price of Astra's Class A common stock is at least $1.00 for a minimum of ten consecutive business days, NASDAQ's staff will provide the Company written notice that it complies with the Minimum Bid Price Requirement.



The Company intends to monitor the per share closing bid price of its Class A
common stock and consider available options if its Class A common stock does not
trade at a level likely to result in the Company regaining compliance with
Minimum Bid Price Requirement by April 4, 2023.

If the Company does not regain compliance with the Minimum Bid Price Requirement
by April 4, 2023, the Company may be eligible for an additional 180 calendar day
compliance period. To qualify, Astra would need to, among other things, meet the
continued listing requirement for market value of publicly held shares and all
other initial listing standards for NASDAQ, with the exception of the Minimum
Bid Price Requirement, and provide written notice to Nasdaq that it intends to
cure the deficiency during the second compliance period.

If Nasdaq concludes that the Company will not be able to cure the deficiency
during the second compliance period, or the Company does not make the required
representations, then NASDAQ will give notice that the Company's Class A common
stock is subject to delisting and the Company will be able to appeal that
delisting before a NASDAQ hearings panel.

There can be no assurance that the Company will regain compliance with the
Minimum Bid Price Requirement or that it will otherwise remain in compliance
with the other listing requirements for NASDAQ. The Company had previously
failed to comply with Nasdaq's requirement that its quarterly and annual reports
be timely filed when its annual report on Form 10-K for the year ended December
31, 2022, was filed late as a result of the change in the Company's filer
status. The Company promptly notified Nasdaq when it became aware that its filer
status had changed and its Form 10-K would be late. Please also see Risk Factors
in Part II, Item 1A of this quarterly report on Form 10-Q for more information
about risks associated with the Company's failure to remain in compliance with
the continuing listing standards of NASDAQ.

                                       46

--------------------------------------------------------------------------------

Table of Contents

© Edgar Online, source Glimpses